Final Guidance Details FDA’s Summary Reporting Program

The VMSR program allows manufacturers of many low-risk devices to report adverse events on a quarterly basis. 

The US Food and Drug Administration has finalized a guidance document detailing a program that lets makers of eligible devices report some malfunctions in a summarized quarterly format.

More from Regulation

More from Policy & Regulation